Apogee Therapeutics (APGE) Interest Income - Total (2024 - 2025)

Apogee Therapeutics' (APGE) quarterly Interest Income - Total came in at -$8.7 million in Q4 2025, down 0.58% year-on-year from -$8.8 million in Q4 2024, and down 38.19% on a QoQ basis from -$6.3 million in Q3 2025.

Apogee Therapeutics (APGE) Interest Income - Total (2024 - 2025) Analysis & Trends

Apogee Therapeutics (APGE) has 2 years of Interest Income - Total data on file, last reported at -$8.7 million in Q4 2025.

  • On a quarterly basis, Interest Income - Total fell 0.58% year-over-year to -$8.7 million in Q4 2025; TTM through Dec 2025 was -$30.0 million, a 13.56% increase from a year earlier, with the FY2025 full-year figure at -$30.0 million, up 13.56% from the prior year.
  • Interest Income - Total for Q4 2025 stood at -$8.7 million, down from -$6.3 million in the prior quarter.
  • Over the last five years, Interest Income - Total for APGE reached as high as -$6.1 million in Q1 2024 and fell as low as -$10.3 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Income - Total (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -230,118.75
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Apogee Therapeutics 9.35 Bn 8.29 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -8.73 Mn
Dec 31, 2025 -8.73 Mn
Sep 30, 2025 -6.32 Mn
Sep 30, 2025 -6.32 Mn
Jun 30, 2025 -7.14 Mn
Jun 30, 2025 -7.14 Mn
Mar 31, 2025 -7.84 Mn
Mar 31, 2025 -7.84 Mn
Dec 31, 2024 -8.68 Mn
Dec 31, 2024 -8.68 Mn
Sep 30, 2024 -9.67 Mn
Sep 30, 2024 -9.67 Mn
Jun 30, 2024 -10.31 Mn
Jun 30, 2024 -10.31 Mn
Mar 31, 2024 -6.09 Mn
Mar 31, 2024 -6.09 Mn